The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 354:209-210 January 12, 2006 Number 2
NextNext

Primary Prevention of Sudden Death in Patients with Lamin A/C Gene Mutations

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
To the Editor: Lamin A/C gene mutations are associated with various disorders,1,2 including cardiac abnormalities characterized by atrial fibrillation, conduction-system disturbances, sudden death, and heart failure.3,4 In retrospective analyses, we have previously investigated the high incidence of sudden death among carriers of such mutations.4,5 Although there is consensus regarding the efficacy of implantable cardioverter–defibrillators (ICDs) in the secondary prevention of sudden death in persons with cardiovascular disease and also in primary prevention in patients with a reduced ejection fraction (<35 percent), it is not yet known whether ICD therapy is efficacious as primary prevention in carriers of a lamin A/C . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.